2025 annual financial data
Actuate Therapeutics 2025 Net income growth
Direct answer
Net income growth was 18.54%.
Operating income was -22,495,312 USD and net income was -22,227,852 USD.
Operating cash flow was -19,206,253 USD.
Get free Actuate Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -22,495,312 USD
- Net income
- -22,227,852 USD
- Operating cash flow
- -19,206,253 USD